Literature DB >> 20843993

Assessment of non-small cell lung cancer perfusion: pathologic-CT correlation in 15 patients.

Nunzia Tacelli1, Martine Remy-Jardin, Marie-Christine Copin, Arnaud Scherpereel, Eric Mensier, Sophie Jaillard, Jean-Jacques Lafitte, Ernst Klotz, Alain Duhamel, Jacques Remy.   

Abstract

PURPOSE: To assess tumor perfusion with multi-detector row computed tomography (CT) in patients with non-small cell lung carcinoma and to correlate CT findings with pathologic results.
MATERIALS AND METHODS: This study was approved by the local Ethics Committee, and all patients provided written informed consent, which included information on the radiation exposure at the CT examinations. Fifteen consecutive patients (mean age, 60.5 years ± 7.7 [standard deviation]), including 14 men (mean age, 59.9 years ± 7.5) and one woman (age, 70 years) with histologically proved non-small cell lung carcinoma were prospectively enrolled. Overall, pathologic-CT correlations were examined in 31 focal tumoral zones. Comparative analysis was performed by using the χ(2) or the Fisher exact test for categoric data. For numeric data, group comparisons were performed by using the Mann-Whitney test.
RESULTS: Whole-tumor coverage (mean height, 4.3 cm ± 2.1) was possible in all patients with generation of colored parametric maps of volume transfer constant (K(trans)) and blood volume (BV) by using Patlak analysis. Of the 12 areas that showed high BV, 10 (83%) had a high K(trans); in all 12 cases, the vascular score was high, confirming the presence of numerous tumoral vessels. Nineteen areas showed low BV; when observed concurrently with a high K(trans) (seven of 19), the mean vessel number per area was significantly higher than that seen in areas with low BV and low K(trans) (12 of 19) (P = .038), suggestive of tumoral vessels associated with high interstitial pressure.
CONCLUSION: Whole-tumor perfusion analysis is technically feasible with 64-detector row CT, with two patterns suggestive of high tumoral vascularity. SUPPLEMENTAL MATERIAL: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.10100181/-/DC1. © RSNA, 2010

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843993     DOI: 10.1148/radiol.10100181

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  22 in total

Review 1.  Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.

Authors:  Michael Ingrisch; Steven Sourbron
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-06       Impact factor: 2.745

2.  Computer-Aided Diagnosis of Ground-Glass Opacity Nodules Using Open-Source Software for Quantifying Tumor Heterogeneity.

Authors:  Ming Li; Vivek Narayan; Ritu R Gill; Jyothi P Jagannathan; Maria F Barile; Feng Gao; Raphael Bueno; Jagadeesan Jayender
Journal:  AJR Am J Roentgenol       Date:  2017-10-18       Impact factor: 3.959

3.  Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.

Authors:  Fabien Maldonado; Fenghai Duan; Sushravya M Raghunath; Srinivasan Rajagopalan; Ronald A Karwoski; Kavita Garg; Erin Greco; Hrudaya Nath; Richard A Robb; Brian J Bartholmai; Tobias Peikert
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

4.  Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.

Authors:  J de Castro; M Cobo; D Isla; J Puente; N Reguart; B Cabeza; A Gayete; M Sánchez; M I Torres; J Ferreirós
Journal:  Clin Transl Oncol       Date:  2014-11-06       Impact factor: 3.405

5.  Lung cancer perfusion: can we measure pulmonary and bronchial circulation simultaneously?

Authors:  Xiaodong Yuan; Jing Zhang; Guokun Ao; Changbin Quan; Yuan Tian; Hong Li
Journal:  Eur Radiol       Date:  2012-03-14       Impact factor: 5.315

6.  Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.

Authors:  P Veit-Haibach; D De Ruysscher; W van Elmpt; M Das; Martin Hüllner; H Sharifi; K Zegers; B Reymen; P Lambin; J E Wildberger; E G C Troost
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

7.  Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography.

Authors:  Sushravya Raghunath; Fabien Maldonado; Srinivasan Rajagopalan; Ronald A Karwoski; Zackary S DePew; Brian J Bartholmai; Tobias Peikert; Richard A Robb
Journal:  J Thorac Oncol       Date:  2014-11       Impact factor: 15.609

8.  Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy.

Authors:  Nunzia Tacelli; Teresa Santangelo; Arnaud Scherpereel; Alain Duhamel; Valérie Deken; Ernst Klotz; Alexis Cortot; Jean-Jacques Lafitte; Frédéric Wallyn; Jacques Remy; Martine Remy-Jardin
Journal:  Eur Radiol       Date:  2013-04-04       Impact factor: 5.315

9.  Extracting Information From Previous Full-Dose CT Scan for Knowledge-Based Bayesian Reconstruction of Current Low-Dose CT Images.

Authors:  Hao Zhang; Hao Han; Zhengrong Liang; Yifan Hu; Yan Liu; William Moore; Jianhua Ma; Hongbing Lu
Journal:  IEEE Trans Med Imaging       Date:  2015-11-06       Impact factor: 10.048

10.  Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer.

Authors:  Alexander W Sauter; Daniel Spira; Maximilian Schulze; Christina Pfannenberg; Jürgen Hetzel; Matthias Reimold; Ernst Klotz; Claus D Claussen; Marius S Horger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-10       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.